A systematic review of drug therapy to delay or prevent type 2 diabetes.
about
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic reviewLong term pharmacotherapy for obesity and overweight: updated meta-analysis.Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucoseAlpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucoseLong-term pharmacotherapy for obesity and overweightIndependent and combined effect of diet and exercise in adults with prediabetesEffect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism.Chromium Picolinate for the Prevention of Type 2 Diabetes.GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasisChromium level in prediction of diabetes in pre-diabetic patients.Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus.Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyWaking up from the DREAM of preventing diabetes with drugs.Orlistat in the prevention of diabetes in the obese patientDiabetes prevention: can insulin secretagogues do the job?Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.Oral anti-diabetic drugs for the prevention of Type 2 diabetes.Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials.Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis.The metabolic syndrome in women.Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet.Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.Simultaneous determination of atorvastatin, metformin and glimepiride in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.Diagnosing abnormal glucose tolerance in hypertensive women: are we making the best choice?Precision medicine in diabetes prevention, classification and management.The answer to diabetes prevention: science, surgery, service delivery, or social policy?Japanese Clinical Practice Guideline for Diabetes 2016.
P2860
Q22242077-3CFA2C8D-F531-4D80-A4FF-417D33B05A12Q22242086-65E95B9D-8772-496A-B34C-38FBC7EC3C36Q24240715-96AEA2DC-FB45-480D-AC9A-EBB539A33302Q24244041-697B111E-EB65-4BC4-BF6C-B3642AF8BC83Q24247723-8A3AE35F-F29E-4EC8-B570-54A4CF17B3FFQ26828591-1E025982-B178-43AE-A925-728F3763704AQ33585892-AE6C3BD2-AE19-425D-BD75-30B256435DB0Q34213716-D54B7A14-A7B1-4BAB-8BCD-8697FBB2F185Q34339666-514F5EA0-C632-4514-A455-C47317BAF15DQ34659680-01686A1E-7AAD-4117-9F35-C5ED8464ADA7Q34999753-C7B3D7F3-EFB5-46AB-9857-D0ED9B3D78C8Q35053877-73709E7F-F40A-4964-93B0-B92A80AB22C6Q35128843-E447F450-0E06-4237-BE8B-58F8C9EBDCCCQ35763346-1B5A4E7B-2635-45E8-9CC9-4CFC5DDC2BA5Q36812759-3468A2E6-8C99-41D4-8771-E62BBC412389Q37102832-5AB56018-6ED9-468D-BDD1-0B4771EFE462Q37104853-730ADB1E-AD9E-4DA2-BF01-67E45193E174Q37856436-2BADDE01-A716-4A02-ACE6-DD7A53013465Q38075098-95300765-B756-417C-A4FF-E5DE805BE299Q38183131-08D26F70-8D56-4822-815C-8B40B8D9BB52Q38236171-F4DA3294-A9DB-4E48-828C-31480528799DQ43267027-B8115444-D89A-4BAD-884F-63762C7B1EAAQ43845439-B22505E7-C1FC-4019-AE88-C75A5B8FB943Q46921390-94291AE3-2C3C-4441-93CD-398F88C077F5Q50196774-71E6670F-1F8C-4280-9F12-029A54C4CFDCQ51466229-6B49E1D1-B15B-4141-ACAC-11CFFA99218BQ52677048-DEF9509F-742F-45B3-9244-E78A3A9D2A8FQ53252189-1D9DDB21-0228-4BBA-89F2-E9A2F0293FE8Q55069710-5B98495C-1F51-41C8-AE50-8719DCC29B46
P2860
A systematic review of drug therapy to delay or prevent type 2 diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A systematic review of drug therapy to delay or prevent type 2 diabetes.
@ast
A systematic review of drug therapy to delay or prevent type 2 diabetes.
@en
type
label
A systematic review of drug therapy to delay or prevent type 2 diabetes.
@ast
A systematic review of drug therapy to delay or prevent type 2 diabetes.
@en
prefLabel
A systematic review of drug therapy to delay or prevent type 2 diabetes.
@ast
A systematic review of drug therapy to delay or prevent type 2 diabetes.
@en
P2093
P356
P1433
P1476
A systematic review of drug therapy to delay or prevent type 2 diabetes
@en
P2093
Finlay A McAlister
Janice Varney
Sumit R Majumdar
P304
P356
10.2337/DIACARE.28.3.736
P407
P577
2005-03-01T00:00:00Z